ACTINIUM PHARMACEUTICALS INC's ticker is and the CUSIP is 00507W956. A total of 3 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $93,240 | +358.0% | 12,600 | +384.6% | 0.00% | – |
| Q1 2024 | $20,358 | -36.3% | 2,600 | -51.9% | 0.00% | – |
| Q3 2023 | $31,968 | -86.0% | 5,400 | -82.5% | 0.00% | -100.0% |
| Q2 2023 | $228,536 | -63.9% | 30,800 | -54.0% | 0.00% | -50.0% |
| Q1 2023 | $632,205 | +5.1% | 66,900 | +18.4% | 0.00% | +100.0% |
| Q4 2022 | $601,725 | +342.4% | 56,500 | +207.1% | 0.00% | – |
| Q3 2022 | $136,000 | +23.6% | 18,400 | -19.3% | 0.00% | – |
| Q2 2022 | $110,000 | +27.9% | 22,800 | +35.7% | 0.00% | – |
| Q1 2022 | $86,000 | +59.3% | 16,800 | +86.7% | 0.00% | – |
| Q4 2021 | $54,000 | -46.5% | 9,000 | -21.1% | 0.00% | – |
| Q3 2021 | $101,000 | +431.6% | 11,400 | +375.0% | 0.00% | – |
| Q2 2021 | $19,000 | -87.2% | 2,400 | -87.7% | 0.00% | – |
| Q1 2021 | $149,000 | -79.8% | 19,500 | -79.4% | 0.00% | -100.0% |
| Q4 2020 | $739,000 | +18375.0% | 94,800 | +23600.0% | 0.00% | – |
| Q3 2020 | $4,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING LLC | 66,900 | $632,205 | 0.00% |
| SIMPLEX TRADING, LLC | 22,000 | $207 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |